FDA Approval of Dexcom’s Non-Adjunctive Indication Triggers a New Era in Diabetes Management

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to FDA Approval of Dexcom’s Non-Adjunctive Indication Triggers a New Era in Diabetes Management
DexCom, Inc. (NASDAQ: DXCM) Delayed: 89.17 -0.18 (0.2%)
Previous Close $89.35    52 Week High $96.38 
Open $88.83    52 Week Low $47.92 
Day High $89.68    P/E N/A 
Day Low $88.33    EPS $-0.42 
Volume 3,491,454